Public Will Have Access To "Real-Time" Recall Data
This article was originally published in The Silver Sheet
Executive Summary
MEDICAL DEVICE RECALLS REACH A NEW HIGH IN 2002 at 585, a 10% rise over the previous benchmark set in 2001. Nearly 75% of 2002 recall actions placed in Class II. The upward trend in recalls comes as FDA prepares to launch a new, Internet-based recall system. With the "Recall Enterprise System," the agency aims to provide "real-time" information via the web on corrections and removals actions. The new system is expected to challenge the ability of both manufacturers and FDA to efficiently evaluate and process recall data. [A tabulation of device recalls from 2002 is included]
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.